pubmed-article:12781189 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12781189 | lifeskim:mentions | umls-concept:C0332307 | lld:lifeskim |
pubmed-article:12781189 | lifeskim:mentions | umls-concept:C0392747 | lld:lifeskim |
pubmed-article:12781189 | lifeskim:mentions | umls-concept:C2746042 | lld:lifeskim |
pubmed-article:12781189 | lifeskim:mentions | umls-concept:C1554963 | lld:lifeskim |
pubmed-article:12781189 | pubmed:issue | 12 | lld:pubmed |
pubmed-article:12781189 | pubmed:dateCreated | 2003-6-3 | lld:pubmed |
pubmed-article:12781189 | pubmed:abstractText | Synthesis of thrombin inhibitors and their binding mode to thrombin is described. Modification of the P1 moiety leads to an increased selectivity versus trypsin. The observed selectivity is discussed in view of their thrombin-inhibitor complex X-ray structures. | lld:pubmed |
pubmed-article:12781189 | pubmed:language | eng | lld:pubmed |
pubmed-article:12781189 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12781189 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:12781189 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12781189 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12781189 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12781189 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12781189 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12781189 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12781189 | pubmed:month | Jun | lld:pubmed |
pubmed-article:12781189 | pubmed:issn | 0960-894X | lld:pubmed |
pubmed-article:12781189 | pubmed:author | pubmed-author:HornbergerWil... | lld:pubmed |
pubmed-article:12781189 | pubmed:author | pubmed-author:LangeUdo E... | lld:pubmed |
pubmed-article:12781189 | pubmed:author | pubmed-author:MackHelmutH | lld:pubmed |
pubmed-article:12781189 | pubmed:author | pubmed-author:SeitzWernerW | lld:pubmed |
pubmed-article:12781189 | pubmed:author | pubmed-author:BauckeDoritD | lld:pubmed |
pubmed-article:12781189 | pubmed:author | pubmed-author:HöffkenH... | lld:pubmed |
pubmed-article:12781189 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12781189 | pubmed:day | 16 | lld:pubmed |
pubmed-article:12781189 | pubmed:volume | 13 | lld:pubmed |
pubmed-article:12781189 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12781189 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12781189 | pubmed:pagination | 2029-33 | lld:pubmed |
pubmed-article:12781189 | pubmed:meshHeading | pubmed-meshheading:12781189... | lld:pubmed |
pubmed-article:12781189 | pubmed:meshHeading | pubmed-meshheading:12781189... | lld:pubmed |
pubmed-article:12781189 | pubmed:meshHeading | pubmed-meshheading:12781189... | lld:pubmed |
pubmed-article:12781189 | pubmed:meshHeading | pubmed-meshheading:12781189... | lld:pubmed |
pubmed-article:12781189 | pubmed:meshHeading | pubmed-meshheading:12781189... | lld:pubmed |
pubmed-article:12781189 | pubmed:meshHeading | pubmed-meshheading:12781189... | lld:pubmed |
pubmed-article:12781189 | pubmed:meshHeading | pubmed-meshheading:12781189... | lld:pubmed |
pubmed-article:12781189 | pubmed:meshHeading | pubmed-meshheading:12781189... | lld:pubmed |
pubmed-article:12781189 | pubmed:meshHeading | pubmed-meshheading:12781189... | lld:pubmed |
pubmed-article:12781189 | pubmed:year | 2003 | lld:pubmed |
pubmed-article:12781189 | pubmed:articleTitle | D-Phe-Pro-Arg type thrombin inhibitors: unexpected selectivity by modification of the P1 moiety. | lld:pubmed |
pubmed-article:12781189 | pubmed:affiliation | BASF AG, D-67056, Ludwigshafen, Germany. wolfgang.hoeffken@basf-ag.de | lld:pubmed |
pubmed-article:12781189 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:12781189 | lld:chembl |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12781189 | lld:pubmed |